MC2203A1 - Medicament contre la cryptosporidiose - Google Patents
Medicament contre la cryptosporidioseInfo
- Publication number
- MC2203A1 MC2203A1 MC891287D MC1287D MC2203A1 MC 2203 A1 MC2203 A1 MC 2203A1 MC 891287 D MC891287 D MC 891287D MC 1287 D MC1287 D MC 1287D MC 2203 A1 MC2203 A1 MC 2203A1
- Authority
- MC
- Monaco
- Prior art keywords
- cryptosporidiosis
- prophylaxis
- cryptosporidiasis
- medicine
- animal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898923254A GB8923254D0 (en) | 1989-10-16 | 1989-10-16 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
MC2203A1 true MC2203A1 (fr) | 1992-11-26 |
Family
ID=10664644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC891287D MC2203A1 (fr) | 1989-10-16 | 1989-10-26 | Medicament contre la cryptosporidiose |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0496729B1 (ja) |
JP (1) | JPH05502435A (ja) |
KR (1) | KR920703038A (ja) |
AT (1) | ATE107504T1 (ja) |
AU (1) | AU637772B2 (ja) |
CA (1) | CA2001566A1 (ja) |
DE (1) | DE68916443T2 (ja) |
DK (1) | DK50092A (ja) |
GB (1) | GB8923254D0 (ja) |
HU (1) | HU208625B (ja) |
IE (1) | IE893450A1 (ja) |
MC (1) | MC2203A1 (ja) |
WO (1) | WO1991005550A1 (ja) |
ZA (1) | ZA898143B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9126874D0 (en) * | 1991-12-18 | 1992-02-19 | Wellcome Found | Medicaments |
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
GB9226905D0 (en) * | 1992-12-24 | 1993-02-17 | Wellcome Found | Pharmaceutical preparation |
GB9613309D0 (en) * | 1996-06-25 | 1996-08-28 | Univ Sheffield | Quinone bacterial inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8310141D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Naphthoquinone derivatives |
GB8310140D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Antiprotozoal agents |
-
1989
- 1989-10-16 GB GB898923254A patent/GB8923254D0/en active Pending
- 1989-10-26 KR KR1019920700869A patent/KR920703038A/ko not_active Application Discontinuation
- 1989-10-26 CA CA002001566A patent/CA2001566A1/en not_active Abandoned
- 1989-10-26 DE DE68916443T patent/DE68916443T2/de not_active Expired - Fee Related
- 1989-10-26 AT AT89912649T patent/ATE107504T1/de not_active IP Right Cessation
- 1989-10-26 HU HU9201295A patent/HU208625B/hu not_active IP Right Cessation
- 1989-10-26 WO PCT/GB1989/001287 patent/WO1991005550A1/en active IP Right Grant
- 1989-10-26 EP EP89912649A patent/EP0496729B1/en not_active Expired - Lifetime
- 1989-10-26 MC MC891287D patent/MC2203A1/xx unknown
- 1989-10-26 AU AU45192/89A patent/AU637772B2/en not_active Ceased
- 1989-10-26 ZA ZA898143A patent/ZA898143B/xx unknown
- 1989-10-26 JP JP1511681A patent/JPH05502435A/ja active Pending
- 1989-10-26 IE IE345089A patent/IE893450A1/en unknown
-
1992
- 1992-04-14 DK DK050092A patent/DK50092A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0496729A1 (en) | 1992-08-05 |
KR920703038A (ko) | 1992-12-17 |
DK50092D0 (da) | 1992-04-14 |
EP0496729B1 (en) | 1994-06-22 |
WO1991005550A1 (en) | 1991-05-02 |
CA2001566A1 (en) | 1991-04-16 |
HU9201295D0 (en) | 1992-07-28 |
DE68916443D1 (de) | 1994-07-28 |
HUT60431A (en) | 1992-09-28 |
IE893450A1 (en) | 1991-04-24 |
HU208625B (en) | 1993-12-28 |
AU4519289A (en) | 1991-05-16 |
AU637772B2 (en) | 1993-06-10 |
GB8923254D0 (en) | 1989-12-06 |
DK50092A (da) | 1992-04-14 |
ATE107504T1 (de) | 1994-07-15 |
JPH05502435A (ja) | 1993-04-28 |
ZA898143B (en) | 1991-06-26 |
DE68916443T2 (de) | 1994-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
IT1241997B (it) | Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. | |
ATE179888T1 (de) | Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure | |
ATE198550T1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
ES2157005T3 (es) | Uso del acido boswellico y sus derivados para la inhibicion de la actividad normal y elevada de la elastasa de leucocitos o de la plasmina. | |
NO912414L (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
MC2142A1 (fr) | Medicament contre la toxoplasmose | |
MC2203A1 (fr) | Medicament contre la cryptosporidiose | |
ES2105643T3 (es) | Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer. | |
BR9612316A (pt) | Agente para profilaxia e tratamento de complicações diabéticas | |
GB9126874D0 (en) | Medicaments | |
GEP19970834B (en) | 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone | |
RU2011380C1 (ru) | Способ профилактики и лечения некробактериоза животных | |
IL110888A (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound | |
KR890000089A (ko) | 신장 질환 치료제 |